Will Non-COVID Drugs Again Boost Pfizer's Top Line in Q3 Earnings?

Pfizer (PFE) COVID revenues have been declining due to lower demand. The company records direct sales and alliance revenues from its partner, BioNTech (BNTX) , for the COVID-19 vaccine, Comirnaty, and product revenues from its oral antiviral pill for COVID, Paxlovid.The Zacks Consensus Estimate for third-quarter 2024 direct sales and alliance revenues from Comirnaty is $1.03 billion, while that for Paxlovid is $1.3 billion.Our estimate for direct sales and alliance revenues from Comirnaty is $1.13 billion, ...